期刊文献+

乳腺癌β-catenin cyclinD_1的表达及意义 被引量:4

Expression and significance of β-catenin,cyclinD_1 in breast carcinoma
下载PDF
导出
摘要 目的探讨β-catenin、cyclinD1在乳腺癌中的表达及意义。方法应用免疫组织化学SP法检测99例乳腺癌,56例乳腺增生症和32名正常乳腺组织中β-catenin、cyclinD1的表达,并分析其与乳腺癌临床病理特征的关系。结果 32名正常乳腺组织中β-catenin在细胞膜中强表达,cyclinD1阴性表达。乳腺癌β-catenin异常表达率78.8%,明显高于乳腺增生症42.8%(P<0.01);乳腺癌cyclinD1阳性表达率57.6%,高于乳腺增生症32.1%(P<0.01)。β-catenin异常表达、cyclinD1的过表达与淋巴结转移相关。β-catenin的异常表达与cyclinD1的表达相关。结论β-catenin异常表达是乳腺癌发生发展过程中的重要因子,这个过程可能是通过激活cy-clinD1实现的。β-catenin异常表达和cyclinD1过表达可作为评估乳腺癌转移预后的指标。 Objective To study the expression and significance of β-catenin,cyclinD1 in breast carcinoma.Methods Ninety-nine breast carcinomas,56 breast cystic hyperplasia tissues and 32 normal breast tissues were studied.Immunohistochemistry was used to detect the expressions of β-catenin and cyclinD1,then their relationship with the clinicopathological features of breast carcinomas were analyzed.Results In 32 cases of normal breast tissues,epithelial cells showed equally strong membranous of β-catenin protein at the cell-cell boundaries,but the expression of cyclinD1 was negative.The abnormal rate of β-catenin in breast carcinomas(78.8%) was much higher than that of breast cystic hyperplasia tissues(42.8%)(P0.01).The overexpression of cyclinD1 in breast carcinomas(57.6%) was much higher than that of breast cystic hyperplasia tissues(32.1%)(P0.01).The abnormal expression of β-catenin and the overexpression of cyclinD1 was associated with lymph node metastasis.There was a highly significant association between abnormal expression of β-catenin and overexpression of cyclinD1.Conclusion The abnormal expression of β-catenin plays an important role in the carcinogenesis and progression of human breast carcinoma,the mechanism of which may be up-regulating the expression of cyclinD1.Abnormal expression of β-catenin and the overexpression of cyclinD1 could be considered as useful makers for determining metastasis and prognosis of human breast carcinoma.
出处 《山西医药杂志(上半月)》 CAS 2011年第6期558-560,共3页 Shanxi Medical Journal
关键词 乳腺肿瘤 Β-CATENIN CYCLIND1 Breast tumor β-catenin cyclinD1
  • 相关文献

参考文献9

  • 1Polakis P.Wnt signaling and cancer.Genes Dev,2000,14(15):1837-1851.
  • 2Maruyama K,Ochiai A,Akimoto S,et al.Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.Oncoloby,2000,59(4):302-309.
  • 3Bienz M,Clevers H.Linking colorectal cancer to Wnt signaling.Cell,2000,103(2):311-320.
  • 4Bankfalvi A,Terpe HJ,Breukelmann D,et al.Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression:a comparative study with CD44.Histopathology,1999,34(1):25-34.
  • 5Lim SC,Lee MS.Significance of E-cadherin/beta-catenin complex and cyclinD1 in breast cancer.Oncol Rep,2002,9(5):915-928.
  • 6Lopez-Knowles E,Zardawi SJ,McNeil CM,et al.Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.Cancer Epidemiol Biomarkers Prev,2010,19(1):301-309.
  • 7Chung GG,Zerkowski MP,Ocal IT,et al.Beta-catenin and p53 analyses of a breast carcinoma tissue microarray.Cancer,2004,100(10):2084-2092.
  • 8王珂,任予,何建军,张云锋,陈武科,马清涌.人乳腺癌组织中Wnt/β-catenin信号传导通路的异常表达与Her2阳性表达间的关系[J].西安交通大学学报(医学版),2009,30(5):587-591. 被引量:11
  • 9Ozaki S,Ikeda S,Ishizaki Y,et al.Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer.Oncol Rep,2005,14(6):1437-1443.

二级参考文献9

  • 1杨剑锋,陈森林,刘志红,张芸.乳腺癌组织中E-cadherin、β-catenin及cyclin D1表达的相关性研究[J].癌症,2004,23(7):799-802. 被引量:23
  • 2PELES E,LAMPRECHT R,BEN LR,et al.Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation[J].J Biol Chem,1992,267(17):12266-12274.
  • 3BEN LR,PATERSON HF,MARSHALL CJ,et al.A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway[J].EMBO,1994,13(14):3302-3311.
  • 4WANG K,MA QY,REN Y,et al.Geldanamycin destablizes HER2 tyrosine kinase and suppresses Wnt/β-Catenin signaling in HER2 overexpressing human breast cancer cells[J].Oncology Reports,2007,17(1):89-97.
  • 5HAYES DF,THOR AD.C-erbB-2 in breast cancer development of a clinically useful marker[J].Semin Oncol,2002,29(3):231-245.
  • 6BRENNAN KR,BROWN AM.Wnt proteins in mammary development and cancer[J].J Mammary Gland Biol Neoplasia,2004,9(2):119-131.
  • 7JONSSON M,BORG A,NILBERT M,et al.Involvement of adenomatous polyposis coli (APC)/beta-catenin signaling in human breast cancer[J].Euro J Cancer,2000,36(2):242-248.
  • 8BONVINI P,WON GA,ROSOLEN A,et al.Geldanamycin abrogates ErbB2 association with proteasome-resistant β-Catenin in melanoma cells,increases β-Catenin-E-Cadherin association,and decreases β-Catenin-sensitive transcription[J].Cancer Res,2001,61(4):1671-1677.
  • 9SCHUNRING E,VERHOEVEN E,VAN TINTEREN H,et al.Amplification of gene within the chromosome 11q13 region is indicative of poor prognosis in patient with operable breast cancer[J].Cancer Res,1992,52(19):5229-5234.

共引文献10

同被引文献30

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部